 |
N-acetylgalactosamine-4-sulfatase, recombinant human |
|---|---|
| Trade Name | Naglazyme |
| Orphan Indication | Mucopolysaccharidosis type VI |
| USA Market Approval | USA |
| USA Designation Date | 1999-02-17 00:00:00 |
| Sponsor | BioMarin Pharmaceutical, Inc.;105 Digital Drive;Novato, California, 94949 |
